Testosterone and growth hormone normalization: A retrospective study of health outcomes

Enrique Ginzburg, Alvin Lin, Michael Sigler, Denise Olsen, Nancy Klimas, Alan Mintz

Research output: Contribution to journalArticle

Abstract

Background: Age-related declines in testosterone and growth hormone (GH) are associated with increased adiposity and decreases in lean mass and bone mineral density (BMD). A long-term retrospective study examined the effects of testosterone and/or GH supplementation on body composition and quality of life (QoL). Methods: A database survey assessed the records of 91 men and 97 women (ages 25–82) in treatment groups based on their hormonal status: dehydroepiandrosterone but no hormonal supplementation (control); testosterone only (Tes); GH only (GH); and testosterone plus GH (Tes+GH). Pre- and post-treatment assessments recorded changes in fat and lean mass, BMD, and QoL. Results: After an average of 3 years of treatment, weight decreased in women in the control and Tes+GH groups but remained stable in men in all groups. Tes and Tes+GH produced statistically significant increases in lean mass, reductions in fat mass, and improvements in BMD in both sexes; GH produced similar changes in women. QoL and mood improved in all groups. Treatments were generally safe and well tolerated. Conclusions: In this retrospective survey, treatment with testosterone and/or GH was associated with favorable effects in men and women across a wide age range.

Original languageEnglish (US)
Pages (from-to)79-86
Number of pages8
JournalJournal of Multidisciplinary Healthcare
Volume1
DOIs
StatePublished - Sep 16 2008

Fingerprint

Growth Hormone
Testosterone
Retrospective Studies
Health
Bone Density
Quality of Life
Therapeutics
Fats
Dehydroepiandrosterone
Adiposity
Body Composition
Databases
Weights and Measures

Keywords

  • Body composition
  • Growth hormone
  • Quality of life
  • Testosterone

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Testosterone and growth hormone normalization : A retrospective study of health outcomes. / Ginzburg, Enrique; Lin, Alvin; Sigler, Michael; Olsen, Denise; Klimas, Nancy; Mintz, Alan.

In: Journal of Multidisciplinary Healthcare, Vol. 1, 16.09.2008, p. 79-86.

Research output: Contribution to journalArticle

Ginzburg, Enrique ; Lin, Alvin ; Sigler, Michael ; Olsen, Denise ; Klimas, Nancy ; Mintz, Alan. / Testosterone and growth hormone normalization : A retrospective study of health outcomes. In: Journal of Multidisciplinary Healthcare. 2008 ; Vol. 1. pp. 79-86.
@article{9a28f5599e1b4263ad763de14cb992e9,
title = "Testosterone and growth hormone normalization: A retrospective study of health outcomes",
abstract = "Background: Age-related declines in testosterone and growth hormone (GH) are associated with increased adiposity and decreases in lean mass and bone mineral density (BMD). A long-term retrospective study examined the effects of testosterone and/or GH supplementation on body composition and quality of life (QoL). Methods: A database survey assessed the records of 91 men and 97 women (ages 25–82) in treatment groups based on their hormonal status: dehydroepiandrosterone but no hormonal supplementation (control); testosterone only (Tes); GH only (GH); and testosterone plus GH (Tes+GH). Pre- and post-treatment assessments recorded changes in fat and lean mass, BMD, and QoL. Results: After an average of 3 years of treatment, weight decreased in women in the control and Tes+GH groups but remained stable in men in all groups. Tes and Tes+GH produced statistically significant increases in lean mass, reductions in fat mass, and improvements in BMD in both sexes; GH produced similar changes in women. QoL and mood improved in all groups. Treatments were generally safe and well tolerated. Conclusions: In this retrospective survey, treatment with testosterone and/or GH was associated with favorable effects in men and women across a wide age range.",
keywords = "Body composition, Growth hormone, Quality of life, Testosterone",
author = "Enrique Ginzburg and Alvin Lin and Michael Sigler and Denise Olsen and Nancy Klimas and Alan Mintz",
year = "2008",
month = "9",
day = "16",
doi = "10.2147/JMDH.S4044",
language = "English (US)",
volume = "1",
pages = "79--86",
journal = "Journal of Multidisciplinary Healthcare",
issn = "1178-2390",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Testosterone and growth hormone normalization

T2 - A retrospective study of health outcomes

AU - Ginzburg, Enrique

AU - Lin, Alvin

AU - Sigler, Michael

AU - Olsen, Denise

AU - Klimas, Nancy

AU - Mintz, Alan

PY - 2008/9/16

Y1 - 2008/9/16

N2 - Background: Age-related declines in testosterone and growth hormone (GH) are associated with increased adiposity and decreases in lean mass and bone mineral density (BMD). A long-term retrospective study examined the effects of testosterone and/or GH supplementation on body composition and quality of life (QoL). Methods: A database survey assessed the records of 91 men and 97 women (ages 25–82) in treatment groups based on their hormonal status: dehydroepiandrosterone but no hormonal supplementation (control); testosterone only (Tes); GH only (GH); and testosterone plus GH (Tes+GH). Pre- and post-treatment assessments recorded changes in fat and lean mass, BMD, and QoL. Results: After an average of 3 years of treatment, weight decreased in women in the control and Tes+GH groups but remained stable in men in all groups. Tes and Tes+GH produced statistically significant increases in lean mass, reductions in fat mass, and improvements in BMD in both sexes; GH produced similar changes in women. QoL and mood improved in all groups. Treatments were generally safe and well tolerated. Conclusions: In this retrospective survey, treatment with testosterone and/or GH was associated with favorable effects in men and women across a wide age range.

AB - Background: Age-related declines in testosterone and growth hormone (GH) are associated with increased adiposity and decreases in lean mass and bone mineral density (BMD). A long-term retrospective study examined the effects of testosterone and/or GH supplementation on body composition and quality of life (QoL). Methods: A database survey assessed the records of 91 men and 97 women (ages 25–82) in treatment groups based on their hormonal status: dehydroepiandrosterone but no hormonal supplementation (control); testosterone only (Tes); GH only (GH); and testosterone plus GH (Tes+GH). Pre- and post-treatment assessments recorded changes in fat and lean mass, BMD, and QoL. Results: After an average of 3 years of treatment, weight decreased in women in the control and Tes+GH groups but remained stable in men in all groups. Tes and Tes+GH produced statistically significant increases in lean mass, reductions in fat mass, and improvements in BMD in both sexes; GH produced similar changes in women. QoL and mood improved in all groups. Treatments were generally safe and well tolerated. Conclusions: In this retrospective survey, treatment with testosterone and/or GH was associated with favorable effects in men and women across a wide age range.

KW - Body composition

KW - Growth hormone

KW - Quality of life

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=85028526997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028526997&partnerID=8YFLogxK

U2 - 10.2147/JMDH.S4044

DO - 10.2147/JMDH.S4044

M3 - Article

AN - SCOPUS:85028526997

VL - 1

SP - 79

EP - 86

JO - Journal of Multidisciplinary Healthcare

JF - Journal of Multidisciplinary Healthcare

SN - 1178-2390

ER -